"G6PD Genotype and Phenotype in the Clinical Setting"
Mary Relling, PharmD, Endowed Chair
Sarah Morris, PharmD, Clinical Pharmacogenomics Specialist
St. Jude Children’s Research Hospital
"Human Genetics and Drug Discovery"
Robert Plenge, MD, PhD
Sr. Vice President - Research & Early Development
Bristol Myers Squibb
"Genetics of Statin-Induced Toxicities in ODYSSEY OUTCOMES Trial Population"
PGRN President's 2020 Poster Award Winner
William (Billy) A. Murphy, PharmD
2nd Year PhD Student
UNC ESHELMAN SCHOOL OF PHARMACY
Division of Pharmacotherapy and Experimental Therapeutics
Chapel Hill, NC
The UK Pharmacogenetics & Stratified Medicine Network is pleased to present our first Virtual Workshop – “Polygenic Risk Scores: Current Status and Future Utility”. The event will be held online and hosted by Professor Sir Munir Pirmohamed.
The first session will include talks on genetic profiling for prediction of Alzheimer’s disease, the impact of PRS on insurance, and the clinical utility of PRS.
The afternoon session will see participants split into breakout groups to discuss:
1. How can we further develop the utility of PRS?
2. What will be the challenges and opportunities of implementing PRS into clinical practice?
3. Ethical issues associated with the use of PRS.
Following these discussions, rapporteurs from each group will present their conclusions.
For more information
Copyright © 2020 the Pharmacogenomics Research Network. All Rights Reserved.
Follow us on